MZF1 and breast cancer: Interestingly, by using CRISPR-Cas9 gene editing technology, we have experienced that ErbB2-expressing breast cancer cell lines have developed dependency on MZF1, so that these cancer cells harboring full knockout of MZF1 are not viable [22], suggesting that they could have developed oncogene addiction towards MZF1.